• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型人肾素抑制剂,其在P2位点含有新型取代基。

New inhibitors of human renin that contain novel replacements at the P2 site.

作者信息

Doherty A M, Kaltenbronn J S, Hudspeth J P, Repine J T, Roark W H, Sircar I, Tinney F J, Connolly C J, Hodges J C, Taylor M D

机构信息

Department of Chemistry, Parke-Davis Pharmaceutical Research Division, Warner-Lambert Company, Ann Arbor, Michigan 48105.

出版信息

J Med Chem. 1991 Apr;34(4):1258-71. doi: 10.1021/jm00108a004.

DOI:10.1021/jm00108a004
PMID:1901910
Abstract

A series of renin inhibitors with novel modifications at the P2 site has been prepared. Structure-activity relationships reveal that for a particular P2 fragment the in vitro potency is highly dependent on the nature of the P2' portion in addition to the P1-P1' group. The length of the P2 side chain and choice of epsilon-N P2 substitution have been found to be important for in vitro potency although the degree of unsaturation in the P2 side chain is not particularly significant. Molecular modeling studies have shown that it is possible for the P2 side chain to interact unfavorably with the P2' binding site. It has been possible to control the specificity for renin over cathepsin D by correct modification at the P2' and P1-P1' sites. Variations at the P4 site have been utilized to lower the log P values of these renin inhibitors while maintaining high potency. Compound 42, which exhibited an IC50 of 3.70 nM, log P of 2.3, and showed high specificity for renin, was selected for further studies. It was found to be very stable under neutral, acidic, and basic conditions. In simulated intestinal juice, compound 42 had a half-life of 37 min while it was virtually unaffected by simulated gastric juice after 4 h. Compound 42 produced a significant hypotensive response upon intravenous administration to the salt-depleted normotensive cynomolgus monkey.

摘要

已制备了一系列在P2位点具有新型修饰的肾素抑制剂。构效关系表明,对于特定的P2片段,除了P1-P1'基团外,体外活性高度依赖于P2'部分的性质。已发现P2侧链的长度和ε-N P2取代基的选择对体外活性很重要,尽管P2侧链的不饱和度程度不是特别显著。分子模拟研究表明,P2侧链有可能与P2'结合位点发生不利相互作用。通过在P2'和P1-P1'位点进行正确修饰,可以控制肾素相对于组织蛋白酶D的特异性。已利用P4位点的变化来降低这些肾素抑制剂的log P值,同时保持高效活性。选择表现出IC50为3.70 nM、log P为2.3且对肾素具有高特异性的化合物42进行进一步研究。发现它在中性、酸性和碱性条件下非常稳定。在模拟肠液中,化合物42的半衰期为37分钟,而在4小时后几乎不受模拟胃液的影响。化合物42静脉注射给低盐正常血压食蟹猴后产生了显著的降压反应。

相似文献

1
New inhibitors of human renin that contain novel replacements at the P2 site.新型人肾素抑制剂,其在P2位点含有新型取代基。
J Med Chem. 1991 Apr;34(4):1258-71. doi: 10.1021/jm00108a004.
2
Design and synthesis of potent, selective, and orally active fluorine-containing renin inhibitors.
J Med Chem. 1992 Jan;35(1):2-14. doi: 10.1021/jm00079a001.
3
Design, structure-activity, and molecular modeling studies of potent renin inhibitory peptides having N-terminal Nin-For-Trp (Ftr): angiotensinogen congeners modified by P1-P1' Phe-Phe, Sta, Leu psi[CH(OH)CH2]Val or leu psi[CH2NH]Val substitutions.具有N端Nin-For-Trp(Ftr)的强效肾素抑制肽的设计、构效关系及分子模拟研究:经P1-P1'苯丙氨酸-苯丙氨酸、斯塔汀、亮氨酸ψ[CH(OH)CH2]缬氨酸或亮氨酸ψ[CH2NH]缬氨酸取代修饰的血管紧张素原类似物
J Med Chem. 1988 Jan;31(1):18-30. doi: 10.1021/jm00396a006.
4
Non-peptide renin inhibitors containing 2-(((3-phenylpropyl)phosphoryl)oxy)alkanoic acid moieties as P2-P3 replacements.
J Med Chem. 1994 Feb 18;37(4):486-97. doi: 10.1021/jm00030a008.
5
Renin inhibitors containing new P1-P1' dipeptide mimetics with heterocycles in P1'.
J Med Chem. 1992 Sep 18;35(19):3525-36. doi: 10.1021/jm00097a010.
6
Renin inhibitors containing esters at the P2-position. Oral activity in a derivative of methyl aminomalonate.
J Med Chem. 1991 Jul;34(7):1935-43. doi: 10.1021/jm00111a002.
7
Design, synthesis, and evaluation of matrix metalloprotease inhibitors bearing cyclopropane-derived peptidomimetics as P1' and P2' replacements.以环丙烷衍生的肽模拟物作为P1'和P2'取代基的基质金属蛋白酶抑制剂的设计、合成与评价
J Org Chem. 2002 Jun 14;67(12):4062-75. doi: 10.1021/jo0110698.
8
Specificity in the binding of inhibitors to the active site of human/primate aspartic proteinases: analysis of P2-P1-P1'-P2' variation.
J Med Chem. 1993 Sep 3;36(18):2614-20. doi: 10.1021/jm00070a004.
9
Novel renin inhibitors containing (2S,3S,5S)-2-amino-1-cyclohexyl-6-methyl-3,5-heptanediol fragment as a transition-state mimic at the P1-P1' cleavage site.
Chem Pharm Bull (Tokyo). 1997 Oct;45(10):1631-41. doi: 10.1248/cpb.45.1631.
10
Renin inhibitors containing conformationally restricted P1-P1' dipeptide mimetics.
J Med Chem. 1991 Mar;34(3):887-900. doi: 10.1021/jm00107a004.

引用本文的文献

1
Evaluation of Virtual Screening Strategies for the Identification of γ-Secretase Inhibitors and Modulators.评价用于鉴定 γ-分泌酶抑制剂和调节剂的虚拟筛选策略。
Molecules. 2021 Dec 28;27(1):176. doi: 10.3390/molecules27010176.